Skip to main content
SpringerLink
Log in

Effect of the T-type channel blocker KYS-05090S in mouse models of acute and neuropathic pain

  • Ion channels, receptors and transporters
  • Published:
Pflügers Archiv - European Journal of Physiology Aims and scope Submit manuscript

Abstract

T-type channels are important contributors to the initiation and the maintenance of chronic pain states. Blocking T-type channels is therefore a possible therapeutic strategy for relieving pain. Here, we report the Cav3.2 T-type channel blocking action of a previously reported small organic molecule, KYS-05090S. This compound was able to reduce transiently expressed Cav3.2 currents with low micromolar affinity and mediated a hyperpolarizing shift in half-inactivation potential. KYS-05090S was then tested in models of acute and neuropathic pain. KYS-05090S (10 μg/10 μl delivered intrathecally) significantly reduced acute pain induced by formalin in both the tonic and inflammatory phases. Its antinociceptive effect was not observed when delivered to Cav3.2 null-mice revealing a Cav3.2-dependent mechanism. KYS-05090S also reduced neuropathic pain in a model of partial sciatic nerve injury. Those results indicate that KYS-05090S mediates a potent analgesic effect in inflammatory and neuropathic pain through T-type channel modulation, suggesting that its scaffold could be explored as a new class of analgesic compounds.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Bladen C, Gadotti VM, Gunduz MG, Berger ND, Simsek R, Safak C, Zamponi GW (2015) 1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain. Pflugers Arch - Eur J Physiol 467:1237–1247. doi:10.1007/s00424-014-1566-3

    Article  CAS  Google Scholar 

  2. Bladen C, McDaniel SW, Gadotti VM, Petrov RR, Berger ND, Diaz P, Zamponi GW (2015) Characterization of novel cannabinoid based T-type calcium channel blockers with analgesic effects. ACS Chem Neurosci 6:277–287. doi:10.1021/cn500206a

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  3. Bourinet E, Alloui A, Monteil A, Barrere C, Couette B, Poirot O, Pages A, McRory J, Snutch TP, Eschalier A et al (2005) Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J 24:315–324. doi:10.1038/sj.emboj.7600515

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  4. Cao XH, Byun HS, Chen SR, Pan HL (2011) Diabetic neuropathy enhances voltage-activated Ca2+ channel activity and its control by M4 muscarinic receptors in primary sensory neurons. J Neurochem 119:594–603. doi:10.1111/j.1471-4159.2011.07456.x

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  5. Cardenas CG, Del Mar LP, Scroggs RS (1995) Variation in serotonergic inhibition of calcium channel currents in four types of rat sensory neurons differentiated by membrane properties. J Neurophysiol 74:1870–1879

    PubMed  CAS  Google Scholar 

  6. Chen CL, Broom DC, Liu Y, de Nooij JC, Li Z, Cen C, Samad OA, Jessell TM, Woolf CJ, Ma Q (2006) Runx1 determines nociceptive sensory neuron phenotype and is required for thermal and neuropathic pain. Neuron 49:365–377. doi:10.1016/j.neuron.2005.10.036

    Article  PubMed  CAS  Google Scholar 

  7. Choi S, Na HS, Kim J, Lee J, Lee S, Kim D, Park J, Chen CC, Campbell KP, Shin HS (2007) Attenuated pain responses in mice lacking Ca(V)3.2 T-type channels. Genes Brain Behav 6:425–431. doi:10.1111/j.1601-183X.2006.00268.x

    Article  PubMed  CAS  Google Scholar 

  8. De Petrocellis L, Moriello AS, Byun JS, Sohn JM, Lee JY, Vazquez-Romero A, Garrido M, Messeguer A, Zhang FX, Zamponi GW et al (2015) Inhibitory effect of positively charged triazine antagonists of prokinecitin receptors on the transient receptor vanilloid type-1 (TRPV1) channel. Pharmacol Res 99:362–369. doi:10.1016/j.phrs.2015.07.009

    Article  PubMed  Google Scholar 

  9. Dziegielewska B, Brautigan DL, Larner JM, Dziegielewski J (2014) T-type Ca2+ channel inhibition induces p53-dependent cell growth arrest and apoptosis through activation of p38-MAPK in colon cancer cells. Mol Cancer Res : MCR 12:348–358. doi:10.1158/1541-7786.MCR-13-0485

    Article  PubMed  CAS  Google Scholar 

  10. Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanpaa M, Hansson P, Jensen TS et al (2015) Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 14:162–173. doi:10.1016/S1474-4422(14)70251-0

    Article  PubMed  CAS  Google Scholar 

  11. Francois A, Kerckhove N, Meleine M, Alloui A, Barrere C, Gelot A, Uebele VN, Renger JJ, Eschalier A, Ardid D et al (2013) State-dependent properties of a new T-type calcium channel blocker enhance Ca(V)3.2 selectivity and support analgesic effects. Pain 154:283–293. doi:10.1016/j.pain.2012.10.023

    Article  PubMed  CAS  Google Scholar 

  12. Francois A, Laffray S, Pizzoccaro A, Eschalier A, Bourinet E (2014) T-type calcium channels in chronic pain: mouse models and specific blockers. Pflugers Arch - Eur J Physiol 466:707–717. doi:10.1007/s00424-014-1484-4

    Article  CAS  Google Scholar 

  13. Gadotti VM, Bladen C, Zhang FX, Chen L, Gündüz MG, Şimşek R, Şafak C, Zamponi GW (2015) Analgesic effect of a broad spectrum dihydropyridine inhibitor of voltage gated calcium channels. Pfulgers Arch

  14. Gadotti VM, You H, Petrov RR, Berger ND, Diaz P, Zamponi GW (2013) Analgesic effect of a mixed T-type channel inhibitor/CB2 receptor agonist. Mol Pain 9:32. doi:10.1186/1744-8069-9-32

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  15. Gadotti VM, Zamponi GW (2011) Cellular prion protein protects from inflammatory and neuropathic pain. Mol Pain 7:59. doi:10.1186/1744-8069-7-59

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  16. Gavva NR, Tamir R, Qu Y, Klionsky L, Zhang TJ, Immke D, Wang J, Zhu D, Vanderah TW, Porreca F et al (2005) AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. J Pharmacol Exp Ther 313:474–484. doi:10.1124/jpet.104.079855

    Article  PubMed  CAS  Google Scholar 

  17. Gunthorpe MJ, Chizh BA (2009) Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway. Drug Discov Today 14:56–67. doi:10.1016/j.drudis.2008.11.005

    Article  PubMed  CAS  Google Scholar 

  18. Hildebrand ME, Smith PL, Bladen C, Eduljee C, Xie JY, Chen L, Fee-Maki M, Doering CJ, Mezeyova J, Zhu Y et al (2011) A novel slow-inactivation-specific ion channel modulator attenuates neuropathic pain. Pain 152:833–843. doi:10.1016/j.pain.2010.12.035

    Article  PubMed  CAS  Google Scholar 

  19. Honore P, Wismer CT, Mikusa J, Zhu CZ, Zhong C, Gauvin DM, Gomtsyan A, El Kouhen R, Lee CH, Marsh K et al (2005) A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats. J Pharm Exp Ther 314:410–421. doi:10.1124/jpet.105.083915

    Article  CAS  Google Scholar 

  20. Hylden JL, Wilcox GL (1980) Intrathecal morphine in mice: a new technique. Eur J Pharmacol 67:313–316

    Article  PubMed  CAS  Google Scholar 

  21. Jacus MO, Uebele VN, Renger JJ, Todorovic SM (2012) Presynaptic Cav3.2 channels regulate excitatory neurotransmission in nociceptive dorsal horn neurons. J Neurosci: Off J Soc Neurosci 32:9374–9382. doi:10.1523/JNEUROSCI.0068-12.2012

    Article  CAS  Google Scholar 

  22. Jagodic MM, Pathirathna S, Joksovic PM, Lee W, Nelson MT, Naik AK, Su P, Jevtovic-Todorovic V, Todorovic SM (2008) Upregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve. J Neurophysiol 99:3151–3156. doi:10.1152/jn.01031.2007

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  23. Jagodic MM, Pathirathna S, Nelson MT, Mancuso S, Joksovic PM, Rosenberg ER, Bayliss DA, Jevtovic-Todorovic V, Todorovic SM (2007) Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons. J Neurosci: Off J Soc Neurosci 27:3305–3316. doi:10.1523/JNEUROSCI.4866-06.2007

    Article  CAS  Google Scholar 

  24. Jensen TS, Madsen CS, Finnerup NB (2009) Pharmacology and treatment of neuropathic pains. Curr Opin Neurol 22:467–474. doi:10.1097/WCO.0b013e3283311e13

    Article  PubMed  CAS  Google Scholar 

  25. Jung SY, Lee SH, Kang HB, Park HA, Chang SK, Kim J, Choo DJ, Oh CR, Kim YD, Seo JH et al (2010) Antitumor activity of 3,4-dihydroquinazoline dihydrochloride in A549 xenograft nude mice. Bioorg Med Chem Lett 20:6633–6636. doi:10.1016/j.bmcl.2010.09.020

    Article  PubMed  CAS  Google Scholar 

  26. Kang HB, Rim HK, Park JY, Choi HW, Choi DL, Seo JH, Chung KS, Huh G, Kim J, Choo DJ et al (2012) In vivo evaluation of oral anti-tumoral effect of 3,4-dihydroquinazoline derivative on solid tumor. Bioorg Med Chem Lett 22:1198–1201. doi:10.1016/j.bmcl.2011.11.083

    Article  PubMed  CAS  Google Scholar 

  27. Malmberg AB, Basbaum AI (1998) Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates. Pain 76:215–222

    Article  PubMed  CAS  Google Scholar 

  28. Mantyh P (2013) Bone cancer pain: causes, consequences, and therapeutic opportunities. Pain 154(Suppl 1):S54–S62. doi:10.1016/j.pain.2013.07.044

    Article  PubMed  Google Scholar 

  29. Messinger RB, Naik AK, Jagodic MM, Nelson MT, Lee WY, Choe WJ, Orestes P, Latham JR, Todorovic SM, Jevtovic-Todorovic V (2009) In vivo silencing of the Ca(V)3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy. Pain 145:184–195. doi:10.1016/j.pain.2009.06.012

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  30. Petruska JC, Napaporn J, Johnson RD, Gu JG, Cooper BY (2000) Subclassified acutely dissociated cells of rat DRG: histochemistry and patterns of capsaicin-, proton-, and ATP-activated currents. J Neurophysiol 84:2365–2379

    PubMed  CAS  Google Scholar 

  31. Rim HK, Cho S, Shin DH, Chung KS, Cho YW, Choi JH, Lee JY, Lee KT (2014) T-type Ca2+ channel blocker, KYS05090 induces autophagy and apoptosis in A549 cells through inhibiting glucose uptake. Molecules 19:9864–9875. doi:10.3390/molecules19079864

    Article  PubMed  Google Scholar 

  32. Snider WD, McMahon SB (1998) Tackling pain at the source: new ideas about nociceptors. Neuron 20:629–632

    Article  PubMed  CAS  Google Scholar 

  33. Stucky CL, Lewin GR (1999) Isolectin B(4)-positive and -negative nociceptors are functionally distinct. J Neurosci: Off J Soc Neurosci 19:6497–6505

    CAS  Google Scholar 

  34. Takahashi T, Aoki Y, Okubo K, Maeda Y, Sekiguchi F, Mitani K, Nishikawa H, Kawabata A (2010) Upregulation of Ca(v)3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain. Pain 150:183–191. doi:10.1016/j.pain.2010.04.022

    Article  PubMed  CAS  Google Scholar 

  35. Todorovic SM, Jevtovic-Todorovic V (2007) Regulation of T-type calcium channels in the peripheral pain pathway. Channels 1:238–245

    Article  PubMed  Google Scholar 

  36. Wen XJ, Xu SY, Chen ZX, Yang CX, Liang H, Li H (2010) The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia. Pharmacology 85:295–300. doi:10.1159/000276981

    Article  PubMed  CAS  Google Scholar 

  37. Yue J, Liu L, Liu Z, Shu B, Zhang Y (2013) Upregulation of T-type Ca2+ channels in primary sensory neurons in spinal nerve injury. Spine 38:463–470. doi:10.1097/BRS.0b013e318272fbf8

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physiology and Pharmacology, Hotchkiss Brain Institute and Alberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, T2N 4N1, Canada

    Saïd M’Dahoma, Vinicius M. Gadotti, Fang-Xiong Zhang & Gerald W. Zamponi

  2. Department of Life and Environmental Sciences, Unit of Pharmaceutical, Pharmacological and Nutraceutical Sciences, University of Cagliari, 09124, Cagliari, Italy

    Valentina Onnis & Gianfranco Balboni

  3. Research Institute for Basic Sciences and Department of Chemistry, College of Sciences, Kyung Hee University, Seoul, 130-701, Republic of Korea

    Byeongyeon Park, Ji Hye Nam & Jae Yeol Lee

Authors
  1. Saïd M’Dahoma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vinicius M. Gadotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fang-Xiong Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Byeongyeon Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ji Hye Nam
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Valentina Onnis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gianfranco Balboni
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jae Yeol Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Gerald W. Zamponi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Gianfranco Balboni, Jae Yeol Lee or Gerald W. Zamponi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

M’Dahoma, S., Gadotti, V.M., Zhang, FX. et al. Effect of the T-type channel blocker KYS-05090S in mouse models of acute and neuropathic pain. Pflugers Arch - Eur J Physiol 468, 193–199 (2016). https://doi.org/10.1007/s00424-015-1733-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00424-015-1733-1

Keywords

Search

Navigation